Cargando…
Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial)
Despite several treatment options and an initial high response rate to androgen deprivation therapy, the majority of prostate cancers will eventually become castration-resistant in the metastatic stage (mCRPC). Androgen receptor splice variant 7 (ARV7) is one of the best-characterized androgen recep...
Autores principales: | Bratic Hench, Ivana, Cathomas, Richard, Costa, Luigi, Fischer, Natalie, Gillessen, Silke, Hench, Jürgen, Hermanns, Thomas, Kremer, Eloïse, Mingrone, Walter, Pereira Mestre, Ricardo, Püschel, Heike, Rothermundt, Christian, Ruiz, Christian, Tolnay, Markus, Von Burg, Philippe, Bubendorf, Lukas, Vlajnic, Tatjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721786/ https://www.ncbi.nlm.nih.gov/pubmed/31374981 http://dx.doi.org/10.3390/cancers11081099 |
Ejemplares similares
-
Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer
por: Hench, Ivana Bratić, et al.
Publicado: (2018) -
Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16)
por: Gillessen, Silke, et al.
Publicado: (2023) -
Fast routine assessment of MGMT promoter methylation
por: Hench, Ivana Bratic, et al.
Publicado: (2020) -
A Tissue-Specific Approach to the Analysis of Metabolic Changes in Caenorhabditis elegans
por: Hench, Jürgen, et al.
Publicado: (2011) -
Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)
por: Curioni-Fontecedro, Alessandra, et al.
Publicado: (2019)